vs
HARVARD BIOSCIENCE INC（HBIO）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是HARVARD BIOSCIENCE INC的1.8倍（$43.2M vs $23.7M），万物新生净利率更高（16.9% vs -12.0%，领先28.9%）
哈佛生物科学是一家全球生命科学设备开发商、制造商与销售商，其产品主要用于支撑科研开发与药物研发工作，目前该公司在纳斯达克上市，股票交易代码为HBIO。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
HBIO vs RERE — 直观对比
营收规模更大
RERE
是对方的1.8倍
$23.7M
净利率更高
RERE
高出28.9%
-12.0%
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $23.7M | $43.2M |
| 净利润 | $-2.8M | $7.3M |
| 毛利率 | 59.7% | — |
| 营业利润率 | 7.2% | — |
| 净利率 | -12.0% | 16.9% |
| 营收同比 | -3.3% | — |
| 净利润同比 | -15916.7% | — |
| 每股收益（稀释后） | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBIORERE
| Q4 25 | $23.7M | — | ||
| Q3 25 | $20.6M | — | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $21.8M | — | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $22.0M | — | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $24.5M | — |
净利润HBIORERE
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-50.3M | — | ||
| Q4 24 | $18.0K | — | ||
| Q3 24 | $-4.8M | — | ||
| Q2 24 | $-2.9M | — | ||
| Q1 24 | $-4.7M | — |
毛利率HBIORERE
| Q4 25 | 59.7% | — | ||
| Q3 25 | 58.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 58.1% | — | ||
| Q2 24 | 57.2% | — | ||
| Q1 24 | 60.3% | — |
营业利润率HBIORERE
| Q4 25 | 7.2% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -228.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | -8.5% | — | ||
| Q2 24 | -9.0% | — | ||
| Q1 24 | -9.3% | — |
净利率HBIORERE
| Q4 25 | -12.0% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | -11.2% | — | ||
| Q1 25 | -231.2% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -21.9% | — | ||
| Q2 24 | -12.7% | — | ||
| Q1 24 | -19.1% | — |
每股收益（稀释后）HBIORERE
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $-1.14 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.11 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $228.0M |
| 总债务越低越好 | $35.9M | — |
| 股东权益账面价值 | $13.7M | $557.1M |
| 总资产 | $80.1M | $722.9M |
| 负债/权益比越低杠杆越低 | 2.61× | — |
8季度趋势，按日历期对齐
现金及短期投资HBIORERE
| Q4 25 | $8.6M | — | ||
| Q3 25 | $6.8M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $4.3M | — |
总债务HBIORERE
| Q4 25 | $35.9M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $36.4M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.6M | — |
股东权益HBIORERE
| Q4 25 | $13.7M | — | ||
| Q3 25 | $14.1M | — | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $14.8M | — | ||
| Q4 24 | $63.3M | — | ||
| Q3 24 | $65.3M | — | ||
| Q2 24 | $67.2M | — | ||
| Q1 24 | $68.8M | — |
总资产HBIORERE
| Q4 25 | $80.1M | — | ||
| Q3 25 | $78.0M | — | ||
| Q2 25 | $80.1M | — | ||
| Q1 25 | $79.8M | — | ||
| Q4 24 | $126.6M | — | ||
| Q3 24 | $131.2M | — | ||
| Q2 24 | $128.9M | — | ||
| Q1 24 | $133.2M | — |
负债/权益比HBIORERE
| Q4 25 | 2.61× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-545.0K | — |
| 自由现金流率自由现金流/营收 | -2.3% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.5M | — |
8季度趋势，按日历期对齐
经营现金流HBIORERE
| Q4 25 | $-96.0K | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-842.0K | — | ||
| Q2 24 | $-846.0K | — | ||
| Q1 24 | $1.4M | — |
自由现金流HBIORERE
| Q4 25 | $-545.0K | — | ||
| Q3 25 | $877.0K | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.7M | — | ||
| Q1 24 | $758.0K | — |
自由现金流率HBIORERE
| Q4 25 | -2.3% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | -7.2% | — | ||
| Q1 24 | 3.1% | — |
资本支出强度HBIORERE
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 2.6% | — |
现金转化率HBIORERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 95.83× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
RERE
暂无分部数据
